Noxopharm (ASX:NOX)
Company Profile
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Noxopharm.
RELATED STOCKHEAD STORIES
Health Check: Trump says a pharma tax is in the offing – with no negotiation
Health Check: Star biotech stocks are going cheap – or cheaper than they were
Bargain Barrel: Four ASX cancer-fighting stocks with market caps under $35 million
Health Check: Sonic Healthcare is cashed up and ready to boom as earnings improve
Health Check: Control Bionics eyes 20pc revenue growth and ‘near term’ profitability
Alive and Kicking: Noxopharm has difficult brain cancer in its sights
Top 10 at 11: Copper finds and cancer drugs are in the morning news
Market Highlights: Oil, iron ore stocks on watch; and should we worry about the ‘September Effect’?
ASX Health Stocks: CBL targets more reimbursement revenue for NeuroNode device
Rise and Shine: Everything you need to know before the ASX opens
ASX Health Stocks: Noxopharm soars 40pc on pancreatic tumour-tackling drug results
Rise and Shine: Everything you need to know before the ASX opens
Closing Bell: Buyers ambush benchmark setting new benchmark
